Skip to main content Skip to navigation
Hamburger Menu
Search icon
Country Selector Country Selector
Europe (English)
Products

Discover & Learn

Resources & Tools

Support

Search icon Search icon
Close Menu
    Alert Icon
    TITLE 2 APPS AND SOLS FREE FORM TEST FEATURES AND SPECS TEXT AND DOWNLOAD SECTION TESTIMONIAL TEXT AND IMAGE
    TITLE 2

    Title

    Sub title
    1. Point with number
    • Point with bullet
    performance1

    APPS AND SOLS

    Applications and Solutions

    Content1
    • Description 1
    • Description 2
    • Description 3
    • Description 4
    • Description 5
    1. Desc 1
    2. Desc 2
    3. Desc 3

     

     
    Test title 2

    Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
    Accordion section
    Accordion title
    Accordion sub title

    • Section description

    • Second desc

    Description for checking the image alignment

     

    trial123

    trial123

    ASR Table Clinical

    Measures Reagents Mechanisma Technology
    Wang F, et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020 May;5(10):e137799. doi: 10.1172/jci.insight.137799 21 COVID‑19 Patients Extremely Severe vs Severe vs Moderate Cases Total lymphocytes, total CD4+ and CD8+ T cells, B cells (absolute count) Total T cells, CD4+ cells (%) CD45RA+ Naïve Tregs (%) CD4+ CD28+ and CD8+ CD28+ T cells (%) CD86+ Dendritic cells (%) Total lymphocytes, total CD4+ and CD8+ T cells, B cells (absolute count) Total T cells, CD4+ cells (%) CD45RA+ Naïve Tregs (%) CD4+ CD28+ and CD8+ CD28+ T cells (%) CD86+ Dendritic cells (%)
    Wang F, et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020 May;5(10):e137799. doi: 10.1172/jci.insight.137799 65 COVID‑19 Patients Extremely Severe vs Severe vs Moderate Cases Total lymphocytes, total CD4+ and CD8+ T cells, B cells (absolute count) Total T cells, CD4+ cells (%) CD45RA+ Naïve Tregs (%) CD4+ CD28+ and CD8+ CD28+ T cells (%) CD86+ Dendritic cells (%)
    Wang F, et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020 May;5(10):e137799. doi: 10.1172/jci.insight.137799 21 COVID‑19 Patients Extremely Severe vs Severe vs Moderate Cases Total lymphocytes, total CD4+ and CD8+ T cells, B cells (absolute count) Total T cells, CD4+ cells (%) CD45RA+ Naïve Tregs (%) CD4+ CD28+ and CD8+ CD28+ T cells (%) CD86+ Dendritic cells (%)
    Wang F, et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020 May;5(10):e137799. doi: 10.1172/jci.insight.137799 65 COVID‑19 Patients Extremely Severe vs Severe vs Moderate Cases Total lymphocytes, total CD4+ and CD8+ T cells, B cells (absolute count) Total T cells, CD4+ cells (%) CD4+ CD28+ and CD8+ CD28+ T cells (%) CD86+ Dendritic cells (%)
    Wang F, et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020 May;5(10):e137799. doi: 10.1172/jci.insight.137799 21 COVID‑19 Patients Extremely Severe vs Severe vs Moderate Cases Total lymphocytes, total CD4+ and CD8+ T cells, B cells (absolute count) Total T cells, CD4+ cells (%) CD45RA+ Naïve Tregs (%) CD4+ CD28+ and CD8+ CD28+ T cells (%) CD86+ Dendritic cells (%)
    Wang F, et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020 May;5(10):e137799. doi: 10.1172/jci.insight.137799 65 COVID‑19 Patients Extremely Severe vs Severe vs Moderate Cases Total lymphocytes, total CD4+ and CD8+ T cells, B cells (absolute count) Total T cells, CD4+ cells (%) CD4+ CD28+ and CD8+ CD28+ T cells (%) CD86+ Dendritic cells (%)
    Wang F, et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020 May;5(10):e137799. doi: 10.1172/jci.insight.137799 21 COVID‑19 Patients Extremely Severe vs Severe vs Moderate Cases Total lymphocytes, total CD4+ and CD8+ T cells, B cells (absolute count) Total T cells, CD4+ cells (%) CD4+ CD28+ and CD8+ CD28+ T cells (%) CD86+ Dendritic cells (%)
    Wang F, et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020 May;5(10):e137799. doi: 10.1172/jci.insight.137799 65 COVID‑19 Patients Extremely Severe vs Severe vs Moderate Cases Total lymphocytes, total CD4+ and CD8+ T cells, B cells (absolute count) Total T cells, CD4+ cells (%) CD4+ CD28+ and CD8+ CD28+ T cells (%) CD86+ Dendritic cells (%)

    The BD FACSLyric™ Flow Cytometry System—A Next-Generation Flow Cytometer

    Built on a foundation of excellence, experience and expertise, the BD FACSLyric™ Flow Cytometry System is a new standard for cell analysis, transforming the way your lab does flow cytometry. As with all BD instruments, the BD FACSLyric™ Flow Cytometry System is backed by 40 years of BD expert training, service and support—so there’s no limit to your potential.

    Test

    This is a test

    TEXT AND DOWNLOAD SECTION
    TEXT AND DOWNLOAD TITLE
    prev
    next

    DESC1

    DESC1

    TT
    DP
    UV

    DESC2

    DESC2

    N2
    DP2
    UV2
    prev
    next
    DOWNLOADS

    TEXT AND IMAGE

    Website Feedback